Retatrutide is an investigational triple agonist developed by Eli Lilly that targets GLP-1, GIP and glucagon receptors, and early trials suggest very strong ...

The lawsuit challenges FDA decisions since 2000 that approved and loosened restrictions on abortion drugs like mifepristone, ...

Founder Vince Sanders told KSHB 41 he has invested nearly $30 million into producing and marketing synthetic 7-OH. He claims ...

A proposed new federal law could provide some competitive guardrails for the company's most important product.

State lawmakers’ decision earlier this year to restrict non-FDA-approved vape products is now hitting local businesses hard ...

The weekly injection was approved by the US Food and Drug Administration in 2017 for people with type 2 diabetes.

Two Republican-led states are challenging more than two decades of federal decisions that allowed mifepristone to be approved ...

A lawsuit filed by Florida and Texas is challenging more than two decades of federal government decisions that have cleared ...

America has a medical bureaucracy problem that’s slowing the adoption of vital preventative technologies, writes Kevin ...

The FDA issued a nationwide recall of ReBoost nasal spray after tests found mold, yeast, and microbial contamination that could pose life-threatening risks to immunocompromised individuals. Consumers ...

A legal opioid readily available across America has sparked public warnings and increased state oversight, yet the drug is ...

WASHINGTON — In 2008, Tracy Beth Høeg, then a resident physician and ultramarathon runner, expressed dismay at vice presidential candidate Sarah Palin’s denial of climate change.